Peripheral blood T Regulatory cell counts may not predict transplant rejection

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Huang, Yuchuan ^a,b   Shan, Juan ^a   Zhang, Chuntao ^a   Zhang, Jie ^a   Feng, Li ^a   Li, Shengfu ^a   Li, Youping ^a,c  

^a SICHUAN UNIVERSITY   (China)

^b China Tobacco Chuanyu Industrial Corporation   (China)

^c Chinese Evidence Based Medicine/Cochrane Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; INTERLEUKIN 10; MESSENGER RNA;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BROWN NORWAY RAT; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CONTROL GROUP; CONTROLLED STUDY; EFFECTOR CELL; GRAFT RECIPIENT; HEART TRANSPLANTATION; LEWIS RAT; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SINGLE DRUG DOSE; SPLEEN; ALLOTRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; CD4 LYMPHOCYTE COUNT; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALS; CD4 LYMPHOCYTE COUNT; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERLEUKIN-10; LYMPH NODES; MODELS, IMMUNOLOGICAL; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIROLIMUS; SPLEEN; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HOMOLOGOUS;

EID: 77954556166     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-40     Document Type: Article

References (28)

1. Wang ME, Stepkowski SM, Ferraresso M, Kahan BD. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats. Transplantation. 1992, 54(4):704-709.
2. Poston RS, Billingham M, Hoyt EG, Pollard J, Shorthouse R, Morris RE, Robbins RC. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation 1999, 100:67-74.
3. Ikonen TS, Gummert JF, Hayase M, Honda Y, Hausen B, Christians U, Berry GJ, Yock PG, Morris RE. Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates. Transplantation 2000, 70:969-975. 10.1097/00007890-200009270-00015, 11014651.
4. Dambrin C, Klupp J, Bîrsan T, Luna J, Suzuki T, Lam T, Stähr P, Hausen B, Christians U, Fitzgerald P, Berry G, Morris R. Sirolimus (Rapamycin) monotherapy prevents graft vascular disease in nonhuman primate recipients of orthotopic aortic allografts. Circulation 2003, 107:2369-2374. 10.1161/01.CIR.0000065576.80196.A4, 12719285.
5. Gao W, Lu Y, El Essawy B, Oukka M, Kuchroo VK, Strom TB. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007, 7:1722-1732. 10.1111/j.1600-6143.2007.01842.x, 17511761.
6. Wood KJ, Sakaguchi S, Regulatory T. cells in transplantation tolerance. Nature Review Immonology 2003, 3:199-210.
7. Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006, 12:277-284. 10.1002/lt.20612, 16447185.
8. Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+Foxp3+ regulatory T cells in renal transplant recipients. Transplantation 2006, 82:550-557. 10.1097/01.tp.0000229473.95202.50, 16926600.
9. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005, 105:4743-4748. 10.1182/blood-2004-10-3932, 15746082.
10. Shan J, Huang YC, Feng L, Ke NW, Luo L, Li CW, Li YP. A modified technique for heterotopic heart transplantation in rats. Journal of Surgical Research
11. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969, 57:225-229.
12. Streit F, Christians U, Schiebel HM, Napoli KL, Ernst L, Linck A, Kahan BD, Sewing KF. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry. Clin Chem 1996, 42:1417-1425.
13. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunological Reviews. 2006, 212:28-50.
14. Schmidt-Lucke C, Aicher A, Romagnani P, Gareis B, Romagnani S, Zeiher AM, Dimmeler S. Specific recruitment of CD4+CD25+ regulatory T cells into the allograft in heart transplant recipients. Am J Physiol Heart Circ Physiol 2007, 292:2425-2431.
15. Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C, Fietta A, Vitulo P, Pozzi E, Viganò M. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc 2003, 35:1523-1526. 10.1016/S0041-1345(03)00476-7, 12826211.
16. Baan CC, van der Mast BJ, Klepper M, et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 2005, 80:110. 10.1097/01.TP.0000164142.98167.4B, 16003241.
17. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001, 166:3789-3796.
18. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002, 195:1641-1646. 10.1084/jem.20012097, 2193557, 12070291.
19. Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006, 12:277-284. 10.1002/lt.20612, 16447185.
20. Fryer J, Yatscoff RW, Pascoe EA, Thliveris J. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation 1993, 55:340-345. 10.1097/00007890-199302000-00021, 8434385.
21. Yakimets WJ, Lakey JR, Yatscoff RW, Katyal D, Ao Z, Finegood DT, Rajotte RV, Kneteman NM. Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses: rapamycin efficacy is blood level related. Transplantation 1993, 56:1293-1298. 10.1097/00007890-199312000-00001, 8278991.
22. Scheffold A, Murphy KM, Hofer T. Competition for cytokines: Treg cells take all. Nature Immunology 2007, 8:1286-1287.
23. Maynard CL, Harrington LE, Janowski KM, James RO, Carlene LZ, Alexander YR, Casey TW. Regulatory T cells expressing interleukin 10 development from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nature Immunology 2007, 8:931-941. 10.1038/ni1504, 17694059.
24. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002, 196:247-253. 10.1084/jem.20020642, 2193931, 12119349.
25. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001, 193:1285-1294. 10.1084/jem.193.11.1285, 2193380, 11390435.
26. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, Roncarolo MG. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002, 196:1335-1346. 10.1084/jem.20021139, 2193983, 12438424.
27. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003, 197:111-119. 10.1084/jem.20021345, 2193798, 12515818.
28. Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 2002, 195:1499-1505. 10.1084/jem.20012076, 2193549, 12045248.